{"id":"W4379281157","doi":"10.1200/jco.2023.41.16_suppl.8003","title":"Talquetamab (tal) + daratumumab (dara) in patients (pts) with relapsed/refractory multiple myeloma (RRMM): Updated TRIMM-2 results.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research; University of Calgary; Princess Margaret Cancer Centre","funders":"Janssen Research and Development","keywords":"Medicine; Daratumumab; Internal medicine; Refractory (planetary science); CD38; Oncology; Tolerability; Gastroenterology; Proteasome inhibitor; Lenalidomide; Multiple myeloma; Adverse effect; CD34","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.006891201,0.0002772244,0.002093034,0.0007391335,0.00007342294,0.00002066575,0.0004120397,0.0007779043,0.000529738],"category_scores_gemma":[0.008776086,0.0001939755,0.0004973775,0.001169497,0.0004301819,0.0002404073,0.0001433026,0.003435473,0.0002393902],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006162488,"about_ca_system_score_gemma":0.002560542,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005152814,"about_ca_topic_score_gemma":0.0002367697,"domain_scores_codex":[0.9927703,0.001130196,0.00370579,0.0004745707,0.00125262,0.0006665859],"domain_scores_gemma":[0.9922377,0.003826723,0.001762348,0.0005585922,0.000954899,0.000659688],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.1999546,0.008048778,0.2959053,0.00005450675,0.0008662594,0.006842284,0.0004169933,0.00008307042,0.002209617,0.00001948575,0.0539413,0.4316578],"study_design_scores_gemma":[0.07580209,0.03203242,0.5981579,0.0001532539,0.000109478,0.0001315727,0.0001515208,0.0002673001,0.000213967,0.00005066905,0.2927551,0.0001747753],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.984054,0.0001078494,0.00000982959,0.004347916,0.001256973,0.0006069799,0.00002278311,0.00004928119,0.009544353],"genre_scores_gemma":[0.9913082,0.0005348729,0.0005629877,0.0008557527,0.0007926479,0.000009653102,0.00009570947,0.00006748085,0.005772686],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4314831,"threshold_uncertainty_score":0.9995734,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1027499321914212,"score_gpt":0.4408975407525841,"score_spread":0.3381476085611629,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}